Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000
Cerebral Sinus Thrombosis Diagnosed by MRI and MR Venography in Cancer Patients
Neurol 54:1222-1226, Raizer,J.J.&DeAngelis,L.M., 2000
Intravenous tPA in Acute Ischemic Stroke Related to Internal Carotid Artery Dissection
Neurol 54:2159-2161, Derex,L.,et al, 2000
Monitoring Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke With Diffusion and Perfusion MRI
Stroke 31:1318-1328, Schellinger,P.D.,et al, 2000
Risk Factors for Peripartum and Postpartum Stroke and Intracranial Venous Thrombosis
Stroke 31:1274-1282, Lanska,D.J.&Kryscio,R.J., 2000
Endovascular Treatment of Dural Sinus Thrombosis With Rheolytic Thrombectomy and Intra-Arterial Thrombolysis
Stroke 31:1420-1425, Chow,K.,et al, 2000
Validity and Reliability of a Quantitative Computed Tomography Score in Predicting Outcome of Hyperacute Stroke Before Thrombolytic Therapy
Lancet 355:1670-1674, Barber,P.A.,et al, 2000
Intravenous Ancrod for Treatment of Acute ischemic Stroke
JAMA 283:2395-2403, Sherman,D.G.,et al, 2000
Ancrod-Is Snake Venom an Antidote for Stroke
JAMA 283:2440-2441, Mayberg,M.R.&Furlan,A., 2000
Transcranial Doppler Ultrasound Criteria for Recanalization After Thrombolysis for Middle Cerebral Artery Stroke
Stroke 31:1128-1132, Burgin,W.S.,et al, 2000
Comparison of Diffusion-Weighted MRI and CT in Acute Stroke
Neurol 54:1557-1561,1548,1549,1552, Lansberg,M.G.,et al, 2000
New magnetic Resonance Imaging Methods for Cerebrovascular Disease: Emerging Clinical Applications
Ann Neurol 47:559-570, Neumann-Haefelin,T.,et al, 2000
Impact on Stroke Subtype Diagnosis of Early Diffusion-Weighted Magnetic Resonance Imaging and Magnetic Resonance Angiography
Stroke 31:1081-1089, Lee,L.J.,et al, 2000
Magnetic Resonance Venography in Idiopathic Pseudotumor Cerebri
J Neuro-Ophthal 20:12-13, Lee,A.G.&Brazis,P.W., 2000
Feasibility and Practicality of MR Imaging of Stroke in the Management of Hyperacute Cerebral Ischemia
AJNR 21:1184-1189, 1177, Schellinger,P.D. et al, 2000
Stroke Mimicry: Four Cases Eligible for Tissue Plasminogen Activator
The Neurologist 6:220-223, Kirshner, H.S., 2000
Facial Palsy in Cerebral Venous Thrombosis
Stroke 31:1766-1769, Straub,J. et al, 2000
Intracranial Vertebrobasilar Stenosis: Angioplasty and Follow-Up
AJNR 21:1293-1301, Nahser,H.C. et al, 2000
Treatment of Acute Ischemic Stroke
NEJM 343:710-722, Brott, T. & Bogousslavsky, J., 2000
Venous Infarcts
Neurol Neurochir Pol 34:937-946, Mendel,T., 2000
Amusement park stroke
Neurol 55:564, Burneo, J.G.,et al, 2000
Headache: Cortical Vein Thrombosis and Response to Anticoagulation
J Emerg Med 17:449-453, Minadeo,J.P &Karaman,B.A., 1999
Acquired Pial Arteriovenous Fistula Following Cerebral Vein Thrombosis
Stroke 30:2487-2490, Phatouros,C.C.,et al, 1999
Cerebral Venous Thrombosis
The Neurologist 5:326-349, Biousse,V.&Bousser,M., 1999
Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999
Cerebral Venous Thrombosis,Nothing,Heparin,or Local Thrombolysis?
Stroke 30:481-483, Bousser,M-G, 1999
Randomized,Placebo-Controlled Trial of Anticoagulant Treatment with Low-Molecular-Weight Heparin for Cerebral Sinus Thrombosis
Stroke 30:484-488,481, de Bruijn,S.F.T.M.,et al, 1999
Cerebral Venous Thrombosis,Combined Intrathrombus rtPA and Intravenous Heparin
Stroke 30:489-494,481, Frey,J.L.,et al, 1999
Evaluation of Early Computed Tomographic Findings in Acute Ischemic Stroke
Stroke 30:389-392, Marks,M.P.,et al, 1999
"Telestroke",The Application of Telemedicine for Stroke
Stroke 30:464-469, Levine,S.R.&Gorman,M., 1999
Intra-Arterial rtPA Treatment of Stroke Assessed by Diffusion- and Perfusion-Weighted MRI
Stroke 30:678-680, Lansberg,M.G.,et al, 1999
Assessment of the Value of MR Imaging for Examining Patients with Angiographically Negative Subarachnoid Hemorrhage
AJR 172:201-206, Rogg,J.M.,et al, 1999
Rapid Thrombectomy of Superior Sagittal Sinus and Transverse Sinus Thrombosis with a Rheolytic Catheter Device
AJNR 20:414-417, Opatowsky,M.J.,et al, 1999
Application of a Rheolytic Thrombectomy Device in the Treatment of Dural Sinus Thrombosis:A New Technique
AJNR 20:568-570, Dowd,C.F.,et al, 1999
Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Deep Cerebral Venous Thrombosis
Stroke 30:1144-1146, Keller,E.,et al, 1999
CT Angiography and Doppler Sonography for Emergency Assessment in Acute Basilar Artery Ischemia
Stroke 30:606-612, Brandt,T.,et al, 1999
Diagnosis and Treatment of Ischemic Stroke
Am J Med 106:211-221, Alberts,M.J., 1999
Acute Vertebrobasilar Occlusion:Treatment with High-Dose Intraarterial Urokinase
AJR 172:709-712, Hoffman,A.I.,et al, 1999
Clinical and Neuroradiological Features of Intracranial Vertebrobasilar Artery Dissection
Stroke 30:1083-1090, Hosoya,T.,et al, 1999
Superselective Intraarterial Fibrinolysis in Central Retinal Artery Occlusion
AJNR 20:565-567, Padolecchia,R.,et al, 1999
Association of Hyperdense Middle Cerebral Artery Sign with Clinical Outcome in Patients Treated with Tissue Plasminogen Activator
Stroke 30:769-772, Manelfe,C.,et al, 1999
Intracranial Stenoocclusive Disease:Double-Detector Helical CT Angiography versus Digital Subtraction Angiography
AJNR 20:791-799,731, Skutta,B.,et al, 1999
Applications of Diffusion-Perfusion Magnetic Resonance Imaging in Acute Ischemic Stroke
Neurol 52:1750-1756,1733, Fisher,M.&Albers,G.W., 1999
Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
NEJM 340:1781-1787, Kwiatkowski,T.G.,et al, 1999
Multiple large and Small Cerebellar Infarcts
JNNP 66:739-745, Sanaple,S.&Bogousslavsky,J., 1999
Dissections of the Internal Carotid Artery:Three-Dimensional Time-of-Flight MR Angiography and MR Imaging Features
AJR 173:139-143, Bousson,V.,et al, 1999
Agreement and Variability in the Interpretation of Early CT Changes in Stroke Patients Qualifying for Intravenous rtPA Therapy
Stroke 30:1528-1533, Grotta,J.C.,et al, 1999
Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999